etidronate has been researched along with Carcinoma, Anaplastic in 8 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twelve consecutive men with disseminated prostate carcinoma were evaluated at 0, 6, and 12 months after treatment with a long acting gonadotropin-releasing hormone agonist (goserelin acetate) and an androgen antagonist (flutamide)." | 7.70 | The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. ( Bryant, C; Campbell, J; Diamond, T; Lynch, W, 1998) |
| "Twelve consecutive men with disseminated prostate carcinoma were evaluated at 0, 6, and 12 months after treatment with a long acting gonadotropin-releasing hormone agonist (goserelin acetate) and an androgen antagonist (flutamide)." | 3.70 | The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. ( Bryant, C; Campbell, J; Diamond, T; Lynch, W, 1998) |
| " The dosage of opiates was decreased in 77% of the patients and could be discontinued in 4 of them." | 2.71 | Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer. ( Anagnostopoulou, US; Datseris, EI; Leondi, AH; Leontopoulou, SA; Papadaki, EK; Rapti, AS; Souvatzoglou, MA; Zerva, CJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leondi, AH | 1 |
| Souvatzoglou, MA | 1 |
| Rapti, AS | 1 |
| Leontopoulou, SA | 1 |
| Papadaki, EK | 1 |
| Datseris, EI | 1 |
| Anagnostopoulou, US | 1 |
| Zerva, CJ | 1 |
| Deprèle, S | 1 |
| Kashemirov, BA | 1 |
| Hogan, JM | 1 |
| Ebetino, FH | 1 |
| Barnett, BL | 1 |
| Evdokimov, A | 1 |
| McKenna, CE | 1 |
| Boedecker, RA | 1 |
| Blake, DG | 1 |
| Sty, JR | 1 |
| Riegert, MR | 1 |
| Shigeno, C | 1 |
| Fukunaga, M | 1 |
| Yamamoto, I | 1 |
| Dokoh, S | 1 |
| Morita, R | 1 |
| Hino, M | 1 |
| Torizuka, K | 1 |
| Diamond, T | 1 |
| Campbell, J | 1 |
| Bryant, C | 1 |
| Lynch, W | 1 |
| Spencer, RP | 1 |
| Smith, JA | 1 |
| Percival, RC | 1 |
| Urwin, GH | 1 |
| Harris, S | 1 |
| Yates, AJ | 1 |
| Williams, JL | 1 |
| Beneton, M | 1 |
| Kanis, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for etidronate and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Topics: Bone Neoplasms; Carcinoma; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organo | 2004 |
Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study.
Topics: Bone Neoplasms; Carcinoma; Clinical Trials as Topic; Double-Blind Method; Etidronic Acid; Humans; Ma | 1989 |
6 other studies available for etidronate and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies.
Topics: Algorithms; Binding Sites; Bone Density Conservation Agents; Carcinoma; Computer Simulation; Crystal | 2008 |
Myocardial uptake. An unexpected finding in an oncology follow-up.
Topics: Aged; Carcinoma; Coronary Disease; Diphosphonates; Etidronic Acid; Follow-Up Studies; Heart; Heart F | 1983 |
Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases.
Topics: Adult; Carcinoma; Diphosphates; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; O | 1982 |
The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Antineoplastic A | 1998 |
Quantifying leukocyte and thrombocyte suppression-recovery after Re-186 HEDP for bone metastases.
Topics: Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Etidronic Acid; Female; F | 2000 |
Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
Topics: Aged; Biopsy; Bone Neoplasms; Bone Resorption; Calcitonin; Carcinoma; Etidronic Acid; Humans; Ilium; | 1987 |